← FDA Drug Approvals (Drugs@FDA)

KRAZATI

NDA · New Drug Application · Sponsor: BRISTOL · Approved 2022-12-12

Drug application

FDA Application #

NDA216340

Application type

New Drug Application

Brand name

KRAZATI

Generic name

ADAGRASIB

Active ingredients

ADAGRASIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL

Manufacturer

Mirati Therapeutics, Inc

First approval

2022-12-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown